These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. mTORC2 is required for proliferation and survival of TSC2-null cells. Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669 [TBL] [Abstract][Full Text] [Related]
43. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348 [TBL] [Abstract][Full Text] [Related]
44. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells. Zheng B; Wang J; Tang L; Shi J; Zhu D Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249 [TBL] [Abstract][Full Text] [Related]
45. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922 [TBL] [Abstract][Full Text] [Related]
46. Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission. McCabe MP; Cullen ER; Barrows CM; Shore AN; Tooke KI; Laprade KA; Stafford JM; Weston MC Elife; 2020 Mar; 9():. PubMed ID: 32125271 [TBL] [Abstract][Full Text] [Related]
48. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. Thomanetz V; Angliker N; Cloëtta D; Lustenberger RM; Schweighauser M; Oliveri F; Suzuki N; Rüegg MA J Cell Biol; 2013 Apr; 201(2):293-308. PubMed ID: 23569215 [TBL] [Abstract][Full Text] [Related]
49. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction. Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905 [TBL] [Abstract][Full Text] [Related]
50. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers. Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158 [TBL] [Abstract][Full Text] [Related]
51. Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex. Gkountakos A; Pilotto S; Mafficini A; Vicentini C; Simbolo M; Milella M; Tortora G; Scarpa A; Bria E; Corbo V Carcinogenesis; 2018 Jul; 39(8):971-980. PubMed ID: 29955840 [TBL] [Abstract][Full Text] [Related]
52. mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis. Morrison MM; Young CD; Wang S; Sobolik T; Sanchez VM; Hicks DJ; Cook RS; Brantley-Sieders DM PLoS Genet; 2015 Jul; 11(7):e1005291. PubMed ID: 26132202 [TBL] [Abstract][Full Text] [Related]
53. mTORC2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis. Zhang S; Qian G; Zhang QQ; Yao Y; Wang D; Chen ZG; Wang LJ; Chen M; Sun SY Cancer Res; 2019 Jul; 79(14):3725-3736. PubMed ID: 31142514 [TBL] [Abstract][Full Text] [Related]
54. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure. Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616 [TBL] [Abstract][Full Text] [Related]
55. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress. Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719 [TBL] [Abstract][Full Text] [Related]
56. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Toschi A; Lee E; Xu L; Garcia A; Gadir N; Foster DA Mol Cell Biol; 2009 Mar; 29(6):1411-20. PubMed ID: 19114562 [TBL] [Abstract][Full Text] [Related]
57. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth. Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247 [TBL] [Abstract][Full Text] [Related]
58. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity. Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526 [TBL] [Abstract][Full Text] [Related]
59. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation. Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732 [TBL] [Abstract][Full Text] [Related]